Centro Internacional de Oftalmología Avanzada, Badajoz, España; Departamento de Oftalmología, Hospital de Zafra, Zafra, Badajoz, España.
Centro Internacional de Oftalmología Avanzada, Badajoz, España.
Arch Soc Esp Oftalmol (Engl Ed). 2020 Jun;95(6):271-278. doi: 10.1016/j.oftal.2020.02.016. Epub 2020 May 15.
To assess if there are any differences in macular and papillary thickness using optical coherence tomography (OCT) in patients with attention deficit hyperactivity disorder (ADHD) compared with a control group, including if there are differences between ADHD patients with and without treatment.
Prospective observational study including 92 eyes of 46 patients divided into 2 groups: 46 eyes of 23 patients with ADHD, and a control group of 46 eyes of 23 healthy patients. The group of patients with ADHD was subdivided into those on treatment with methylphenidate (n=28) and those not on treatment (n=18). The macular thickness, the ganglion cell complex (GCC), and the retinal nerve fibre layer (RNFL) at the papillary level were measured in 12 sectors.
A lower central macular thickness was observed in the ADHD patients than in the controls (257.4±20μm versus 267.5±20μm, P=.013), with no differences observed in the GCC (P=.566), or in the RNFL (P=.095). There were no differences in the patients with ADHD with and without treatment, as regards macular thickness and the GCC (P=.160 and P=.375 respectively), but a lower foveal thickness (P=.018) and RNFL in 5/12 sectors at the papillary level (P=.033) were observed in those without treatment.
A lower macular thickness was observed in patients with ADHD than in controls. In addition, patients with ADHD without treatment had a lower thickness of the fovea and RNFL than those patients on treatment.
使用光学相干断层扫描(OCT)评估注意力缺陷多动障碍(ADHD)患者与对照组之间的黄斑和乳头厚度是否存在差异,包括ADHD 患者治疗与未治疗之间是否存在差异。
前瞻性观察研究,纳入 46 例患者的 92 只眼,分为 2 组:23 例患者的 46 只眼(ADHD 组)和 23 例健康患者的 46 只眼(对照组)。ADHD 患者组再分为接受哌醋甲酯治疗的(n=28)和未治疗的(n=18)。测量 12 个象限的黄斑厚度、节细胞复合体(GCC)和乳头水平的视网膜神经纤维层(RNFL)。
与对照组相比,ADHD 患者的中央黄斑厚度较低(257.4±20μm 与 267.5±20μm,P=.013),但 GCC(P=.566)和 RNFL(P=.095)无差异。治疗与未治疗的 ADHD 患者之间在黄斑厚度和 GCC 方面无差异(分别为 P=.160 和 P=.375),但未治疗的患者在乳头水平的 5/12 个象限中,其黄斑中心凹厚度(P=.018)和 RNFL 较低(P=.033)。
与对照组相比,ADHD 患者的黄斑厚度较低。此外,未治疗的 ADHD 患者的黄斑中心凹和 RNFL 厚度低于接受治疗的患者。